Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 21.64%1.11B | ---- | 0.15%1.06B | ---- | 34.36%911.52M | ---- | 140.97%1.06B | ---- | --678.43M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | 1.20%-19.38M | ---- | 21.60%-31.16M | ---- | 54.16%-19.62M | ---- | ---39.74M | ---- | ---42.8M |
| Impairment and provisions: | ---- | ---- | ---- | -87.86%15.34M | ---- | ---- | ---- | 4,462.12%126.33M | ---- | --530.22K |
| -Other impairments and provisions | ---- | ---- | ---- | 136.30%13.01M | ---- | ---- | ---- | 504.57%5.51M | ---- | --530.22K |
| Asset sale loss (gain): | ---- | ---- | ---- | 81.78%-17.61M | ---- | ---- | ---- | -297.85%-96.65M | ---- | --3.51M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 81.78%-17.61M | ---- | ---- | ---- | -297.85%-96.65M | ---- | --3.51M |
| Depreciation and amortization: | ---- | -2.39%901.45M | ---- | 2.49%2B | ---- | -6.83%923.5M | ---- | 1.40%1.96B | ---- | --991.22M |
| -Amortization of intangible assets | ---- | 0.00%26.4M | ---- | 0.42%52.79M | ---- | 0.60%26.4M | ---- | --52.57M | ---- | --26.24M |
| -Other depreciation and amortization | ---- | -98.87%109.26K | ---- | 38.62%31.82M | ---- | -4.68%9.67M | ---- | 271.24%22.95M | ---- | --10.14M |
| Financial expense | ---- | 52.41%38.92M | ---- | 20.93%103.94M | ---- | -29.00%25.53M | ---- | --85.95M | ---- | --35.96M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -1,171.68%-61.85M | ---- | -52.91%-41.11M | ---- | -56.15%5.77M | ---- | -402.01%-26.88M | ---- | --13.16M |
| Accounts receivable (increase)decrease | ---- | -19.66%-589.58M | ---- | 113.25%231.74M | ---- | 21.77%-492.71M | ---- | -600.76%-1.75B | ---- | ---629.81M |
| Accounts payable increase (decrease) | ---- | 154.42%325.07M | ---- | -71.83%-1.02B | ---- | -18.92%-597.37M | ---- | -178.31%-595.42M | ---- | ---502.31M |
| Special items of business | ---- | -66.32%119.15M | ---- | 2.53%409.53M | ---- | 34.32%353.73M | ---- | --399.44M | ---- | --263.34M |
| Adjustment items of business operations | -3.54%2.09B | 125.13%1.7B | -5.58%849.82M | 220.92%2.3B | 160.31%2.16B | 38.10%756.63M | 785.23%900M | --716.92M | 205.60%831.22M | --547.89M |
| Net cash from operations | -3.54%2.09B | 64.14%1.82B | -5.58%849.82M | 142.78%2.71B | 160.31%2.16B | 36.87%1.11B | 785.23%900M | 677.08%1.12B | 205.60%831.22M | 216.64%811.23M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 51.00%14.25M | -10.98%8.4M | ---- | -86.76%9.44M | -42.05%9.44M | -42.05%9.44M | ---- | 261.46%71.26M | 24.12%16.29M | 24.12%16.29M |
| Sale of fixed assets | 11,108.69%1.91M | 1,309.81%33.05K | ---- | -40.95%9.62M | -99.71%17.02K | -99.96%2.34K | ---- | -85.84%16.29M | -81.36%5.89M | -53.95%5.84M |
| Purchase of fixed assets | 56.56%-425M | 23.86%-314M | 34.59%-146.82M | -26.66%-1.29B | -16.28%-978.36M | 25.69%-412.39M | 27.05%-224.47M | 38.13%-1.02B | -76.21%-841.4M | -123.74%-554.97M |
| Other items in the investment business | --60.01M | --65.86M | --6.41K | ---- | ---- | ---- | ---- | 0.68%111.92M | ---10M | --169.82M |
| Net cash from investment operations | 64.00%-348.83M | 40.51%-239.71M | 34.60%-146.81M | -55.05%-1.28B | -16.84%-968.91M | -11.00%-402.95M | 25.64%-224.47M | 42.29%-822.84M | -87.27%-829.23M | -63.35%-363.02M |
| Net cash before financing | 45.49%1.74B | 123.75%1.58B | 4.07%703.01M | 388.72%1.43B | 59,935.02%1.19B | 57.83%707.41M | 437.47%675.54M | 118.13%293.52M | 100.16%1.99M | 148.84%448.21M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | -66.67%400M | -42.86%400M | -20.00%400M | -20.00%400M | -20.00%1.2B | 0.00%700M | 0.00%500M |
| Refund | -48.15%-600M | -11,900.00%-600M | ---300M | 9.54%-1.09B | 42.14%-405M | 99.00%-5M | ---- | -24,000.00%-1.21B | ---700M | ---500M |
| Dividends paid - financing | 7.19%-318M | 75.63%-5.06M | 72.25%-2.76M | -746.80%-349.6M | -957.28%-342.64M | ---20.78M | 12.94%-9.96M | ---41.28M | -410.87%-32.41M | ---- |
| Other items of the financing business | --105.15M | --17.15M | ---- | 189.04%57.35M | ---- | ---- | ---- | ---64.41M | ---- | ---22.95M |
| Net cash from financing operations | -133.82%-812.85M | -257.11%-587.92M | -177.62%-302.76M | -787.33%-982.24M | -972.71%-347.64M | 1,730.85%374.22M | -20.17%390.04M | -107.80%-110.7M | -104.67%-32.41M | -104.61%-22.95M |
| Effect of rate | -159.80%-33.15K | ---36.59K | --11.57K | --157.81K | -90.20%55.44K | ---- | ---- | ---- | --565.43K | ---- |
| Other items affecting net cash | ---- | ---- | ---2 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 9.25%925.57M | -8.02%994.9M | -62.44%400.25M | 147.38%452.28M | 2,885.27%847.22M | 154.34%1.08B | 269.50%1.07B | 191.49%182.83M | 94.33%-30.42M | 201.24%425.27M |
| Begining period cash | 30.52%1.93B | 30.52%1.93B | 24.64%1.93B | 14.07%1.48B | -2.57%1.48B | 14.07%1.48B | 2.03%1.55B | -13.33%1.3B | -11.51%1.52B | -13.33%1.3B |
| Items Period | ---- | ---- | ---1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash at the end | 22.78%2.86B | 14.26%2.93B | -10.80%2.34B | 30.52%1.93B | 56.18%2.33B | 48.65%2.56B | 44.65%2.62B | 14.07%1.48B | 26.07%1.49B | 59.80%1.72B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.